Hims & Hers Health

$29.72$0.72 (+2.48%)
Last updated on --.

Hims & Hers Health price

24 Hours+2.48%+$0.72
30 days+4.76%+$1.320
60 days-5.92%-$1.870
90 days-17.60%-$6.350

About Hims & Hers Health

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Stock ticker
HIMS
Company
Hims & Hers Health, Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
--
Launch date
Sep 13, 2019
Listed exchange
NYSE

Financials

Q2 FY2026 Earnings
Report period: Apr 1, 2026 – Jun 30, 2026

Summary: HIMS reported Revenue of 753.21M (+38.25%), beating expectations; EPS of -0.37 (-317.65%), missing expectations.

Revenue (USD)Beat753.21M+38.24%698.90M+19.64%54.32M+7.77%
EPS (USD)Missed-0.37-317.65%-0.05-127.67%-0.32-643.13%
Financial estimates
● Actual● Estimate
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
0.170.060.08-0.40-0.37
+200.35%-80.19%-27.28%-300.00%-317.65%
● EPS● YoY
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
1.88B2.23B2.15B2.27B3.63B
1.31B1.65B1.61B1.82B3.30B
70.03%73.98%74.89%80.31%91.06%
● Assets● Liabilities● Ratio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
-19.12M148.72M64.70M89.36M-35.94M
-135.67%+74.41%-25.11%-18.09%-88.00%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.12.38%
Andrew Dudum10.65%
VANGUARD PORTFOLIO MANAGEMENT LLC4.55%
VANGUARD CAPITAL MANAGEMENT LLC4.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP3.88%
Others64.39%
Institutions
% Owned69.34%+3.93%
Shares held158.34M+8.99M
Institutions586+96
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.12.38%+2.37M
Andrew Dudum10.65%0.00
VANGUARD PORTFOLIO MANAGEMENT LLC4.55%+375.50K
VANGUARD CAPITAL MANAGEMENT LLC4.11%+201.67K
SUSQUEHANNA INTERNATIONAL GROUP, LLP3.88%-1.56M

Hims & Hers Health conversion tables

HIMSHIMS
USDUSD
0.5 HIMS14.86 USD
1 HIMS29.72 USD
5 HIMS148.6 USD
10 HIMS297.2 USD
USDUSD
HIMSHIMS
0.5 USD0.016824 HIMS
1 USD0.033647 HIMS
5 USD0.16824 HIMS
10 USD0.33647 HIMS

More to explore

FAQ

HIMS is trading at $29.72, +2.48% over the last 24 hours. Track live moves on the price chart at the top of this page.

The HIMS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. HIMS is currently trading at $29.72, +2.48% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on HIMS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. HIMS's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from HIMS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against HIMS's historical range and other companies in the Healthcare sector.

Hims & Hers Health, Inc.'s market cap is currently 6.59B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.